Cramer Weighs In On Biogen, Caterpillar And More

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Biogen Inc BIIB. He is concerned about the stock because a Baird analyst expressed his skepticism about Biogen's Alzheimer's drug.

Amgen, Inc. AMGN is a much better company than it was six months ago, said Cramer. If it trades back to $210, he would be willing to buy it.

Cramer would sell some Caterpillar Inc. CAT and buy it back at a lower price. He thinks the company isn't going to have a good quarter and he is worried about trade tariffs.

See Also: Can Tesla's Stock Continue Revving After 50% Rally?

ABIOMED, Inc. ABMD has been de-risked and Cramer would buy the stock.

Northrop Grumman Corporation NOC is cheap, said Cramer. He would start buying it within the next couple of days. He likes Lockheed Martin Corporation LMT more.

Cramer would not buy Tegna TGNA. He thinks it's going to be possible to buy it later at a lower price.